Thirty-two states now have legally authorized SSPs, a number which has doubled since 2014 (Fernández-Viña et al., 2020). Regarding SUD treatment, there has been a significant increase in availability of medication for opioid use disorder, especially buprenorphine, over the past two decades (opioid agonist therapies including buprenorphine are often placed under the “umbrella” of harm reduction treatments; Alderks, 2013). Nonabstinence goals have become more widely accepted in SUD treatment in much of Europe, and evidence suggests that acceptance of controlled drinking has increased among U.S. treatment providers since the 1980s and 1990s (Rosenberg, Grant, & Davis, 2020). Importantly, there has also been increasing acceptance of non-abstinence outcomes as a metric for assessing treatment effectiveness in SUD research, even at the highest levels of scientific leadership (Volkow, 2020).
4. Current status of nonabstinence SUD treatment
The desire to avoid lapses may lead one abstinence violation effect to cultivate a pathological inflexible commitment to staying on course. Moreover, disappointment from a lapse causes dieters to engage in binge eating after a broken diet. In many cases, relapse can also affect the brain by causing the abstinence violation effect discussed in this article.
Relapse Prevention
We define nonabstinence treatments as those without an explicit goal of abstinence from psychoactive substance use, including treatment aimed at achieving moderation, reductions in use, and/or reductions in substance-related harms. We first provide an overview of the development of abstinence and nonabstinence approaches within the historical context of SUD treatment in the U.S., followed by an evaluation of literature underlying the theoretical and empirical rationale for nonabstinence treatment approaches. Lastly, we review existing models of nonabstinence psychosocial treatment for SUD among adults, with a special focus on interventions for drug use, to identify gaps in the literature and directions for future research. We identify a clear gap in research examining nonabstinence psychosocial treatment for drug use disorders and suggest that increased research attention on these interventions represents the logical next step for the field. It is important to advance our understanding of the smoking relapse process, so that we might improve our ability to affect clinical outcomes.
2. Established treatment models compatible with nonabstinence goals
The analysis was based on data from a randomized, double-blind, placebo-controlled clinical trial of high-dose nicotine patch for smoking cessation. Clinical outcomes have been reported elsewhere (Shiffman, Ferguson, & Gwaltney, 2006; Shiffman, Scharf, et al., 2006). Participant recruitment and data collection occurred between October 1997 and February 2000.
For example, Miller and colleagues (1996) found that although mere exposure to specific high-risk situations did not predict relapse, the manner in which people coped with those situations strongly predicted subsequent relapse or continued abstinence. Furthermore, in that study the majority of relapse episodes after treatment occurred during situations involving negative emotional states, a finding that has been replicated in other studies (Cooney et al. 1997; McKay 1999; Shiffman 1992). Finally, the results of Miller and colleagues (1996) support the role of the abstinence violation effect in predicting which participants would experience a full-blown relapse following an initial lapse. Specifically, those participants who had a greater belief in the disease model of alcoholism and a higher commitment to absolute abstinence (who were most likely to experience feelings of guilt over their lapse) were most likely to experience relapse in that study.
Miller, whose seminal work on motivation and readiness for treatment led to multiple widely used measures of SUD treatment readiness and the development of Motivational Interviewing, also argued for the importance of goal choice in treatment (Miller, 1985). Drawing from Intrinsic Motivation Theory (Deci, 1975) and the controlled drinking literature, Miller (1985) argued that clients benefit most when offered choices, both for drinking goals and intervention approaches. A key point in Miller’s theory is that motivation for change is “action-specific”; he argues that no one is “unmotivated,” but that people are motivated to specific actions or goals (Miller, 2006).
This is an important measure, but it doesn’t do much for relapse prevention http://uniquedriftwoodcreations.com.www71.jnb2.host-h.net/drinking-alcohol-during-pregnancy-is-it-safe-what/ if we don’t forge a plan to deal with these disturbances when they arise. To account for correlated observations due to repeated measures within subjects (i.e., recurrent lapse events), we used parametric shared-frailty models, the survival-data analog to mixed-effects (i.e., multilevel or hierarchical linear) regression models (Hougaard, 1999; Hosmer, Lemeshow, & May, 2008). These assume that there are individual differences in lapse risk, as well as differences attributable to within-subject variability (i.e., across lapse episodes). “Frailty effects” account for such individual differences in vulnerability, as distinct from factors that influence survival for each individual episode. We expected that individuals more prone to daily resumption and relapse would reach these milestones earlier and thereby drop from the sample of those at risk for an additional lapse. The abstinence violation effect (AVE) describes a common response among people practicing abstinence when relapse occurs.
Temptations neither provoked an AVE nor enhanced self-efficacy in either lapsers or maintainers. Maintainers’ reactions to temptations were nearly identical to lapsers’, except that maintainers felt worse. The data demonstrate the reality of AVE reactions, but do not support hypotheses about their structure or determinants. Alternatively, consider someone in recovery from binge eating disorder who has been working on intuitive eating and breaking the cycle of restrictive dieting.
- In 1990, Marlatt was introduced to the philosophy of harm reduction during a trip to the Netherlands (Marlatt, 1998).
- It has also been shown to promote a decrease in symptoms of anxiety, depression, and specific phobias, all which have a comorbid relationship with substance use disorders.
- Relapse Prevention (RP) is another well-studied model used in both AUD and DUD treatment (Marlatt & Gordon, 1985).
- For example, all studies with SUD populations could include brief questionnaires assessing short-and long-term substance use goals, and treatment researchers could report the extent to which nonabstinence goals are honored or permitted in their study interventions and contexts, regardless of treatment type.
Expanding the continuum of substance use disorder treatment: Nonabstinence approaches
For example, at a large outpatient SUD treatment center in Amsterdam, goal-aligned treatment for drug and alcohol use involves a version of harm reduction psychotherapy that integrates MI and CBT approaches, and focuses on motivational enhancement, self-control training, and relapse prevention (Schippers & Nelissen, 2006). Participants with controlled use goals in this center are typically able to achieve less problematic (38%) or non-problematic (32%) use, while a minority achieve abstinence with (8%) or without (6%) incidental relapse (outcomes were not separately assessed for those with AUD vs. DUD; Schippers & Nelissen, 2006). The cognitive-behavioral model of the relapse process posits a central role for high-risk situations and for the drinker’s response to those situations.
Additional hours of prospective abstinence time across each 1-unit change in post-lapse guilt, plotted separately for those assigned to Active versus Placebo NRT patch. Model-based predicted median hours of prospective abstinence preceding each lapse, plotted as a function of Active versus Placebo NRT patch assignment. Depending on the substance used, alcoholism treatment addiction may also have the potential to damage the brain itself. A person experiencing the AVE might have thoughts like, “Well, I’ve already broken my streak, so I might as well go all-out,” or “Clearly I can’t stay sober, so there’s no point in continuing to try.” This pattern can turn a minor slip-up into a full-blown relapse, leading to more major setbacks. RehabCenter.net is intended for educational purposes only and is not designed to provide medical advice of any kind. Any information found on RehabCenter.net should never be used to diagnose a disease or health problem, and in no way replaces or substitutes professional care.